Morgan Stanley initiates coverage on Accelerant stock with Equalweight rating

Published 18/08/2025, 10:48
Morgan Stanley initiates coverage on Accelerant stock with Equalweight rating

Investing.com - Morgan Stanley initiated coverage on Accelerant Holdings (NYSE:ARX) with an Equalweight rating and a $28.00 price target on Monday. According to InvestingPro data, the stock’s RSI indicates overbought territory, with shares trading near $28.33.

The investment thesis for Accelerant centers on its Risk Exchange platform, which connects managing general agents (MGAs) with risk capital partners, effectively disrupting traditional insurance value chains. The company maintains strong financial health with a current ratio of 8.97, indicating robust liquidity to support its growth initiatives.

Morgan Stanley notes that Accelerant’s exchange written premiums have grown substantially from approximately $1.2 billion in 2022 to around $3.1 billion in 2024, with potential to reach approximately $6.0 billion by 2027.

The firm projects Accelerant will achieve approximately 29% adjusted EBITDA margins by 2027, translating to approximately $339 million in adjusted EBITDA and $184 million in adjusted net income.

Morgan Stanley’s $28 price target is based on EV/EBITDA valuation methodology, with the stock currently trading at approximately 16 times 2027 estimated EV/EBITDA, in line with the peer average.

In other recent news, Accelerant Holdings has been the subject of several analyst ratings, reflecting varied perspectives on the company’s potential. Piper Sandler initiated coverage with an Overweight rating, setting a price target of $35.00, emphasizing the company’s data-driven risk exchange model. RBC Capital also provided an optimistic outlook by initiating coverage with an Outperform rating and a $33.00 price target, highlighting the unique value proposition of Accelerant’s Risk Exchange. Similarly, BMO Capital expressed confidence in Accelerant’s growth potential, offering an Outperform rating and a $34.00 price target, citing the company’s comprehensive insurance ecosystem.

On a different note, Citizens JMP took a more cautious approach, assigning a Market Perform rating, noting Accelerant’s focus on addressing inefficiencies in the insurance market. Meanwhile, Goldman Sachs initiated coverage with a Neutral rating and a $30.00 price target, acknowledging the value created by Accelerant’s data-enabled risk exchange model. These recent developments indicate a range of analyst opinions on Accelerant Holdings’ future prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.